Side Effect Management
PRT yields similar progression-free survival rates to IMRT; outcomes depend largely on the success of surgery prior to radiation therapy.
Electroencephalogram neurofeedback appears to be effective at alleviating symptoms of chemotherapy-induced peripheral neuropathy.
Treatment with certain chemotherapies for early-stage breast cancer was tied to cognitive impairment, but only in those without a history of anxiety.
The FDA has approved telotristat ethyl (Xermelo) for the treatment of adults with carcinoid syndrome diarrhea in combination with somatostatin analog.
Among patients with breast or prostate cancers, mental health conditions are associated with increased outpatient visits, hospital admissions.
Scalp cooling may prevent up to half of hair loss for patients receiving chemotherapy for breast cancer.
Anxiety and depression may increase the risk of death from certain cancers.
Participation in a multidisciplinary clinic is feasible for mitigating treatment-related toxicity among patients with newly diagnosed metastatic prostate cancer.
Five-year toxicity profiles and cosmetic results were similar for patients with low-risk breast cancer who underwent breast-conserving surgery.
In contrast with current guidelines, non-conventional physical activity patterns reduce all-cause, cardiovascular disease (CVD), and cancer mortality.
Drug Info Database
More from Oncology Nurse Advisor
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|